Gainers
- Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
- Pagaya Technologies Ltd. (NASDAQ:PGY) jumped 73.1% to close at $16.74. The stock has seen continued volatility after the company completed its SPAC merger agreement last month.
- Freight Technologies, Inc. (NASDAQ:FRGT) jumped 67.6% to close at $2.48 after the company announced it was awarded Samsung Mexico SDS business and has begun using its platform to assist with effecting Samsung's shipments from Mexico to the United States.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 60.8% to settle at $2.75. Comera Life Sciences reported preclinical topline safety results of lead SQore Excipient.
- InflaRx N.V. (NASDAQ:IFRX) climbed 38.1% to close at $1.92 after the company announced plans to apply for Emergency Use Authorization from the FDA for vilobelimab for the treatment of critically ill COVID-19 patients.
- Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 32% to settle at $1.36.
- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 30.1% to close at $1.22.
- Nutriband Inc. (NASDAQ:NTRB) jumped 28.5% to close at $6.53. Nutriband said 1.2 million shares will be cancelled from total outstanding shares following final court judgment in favor of the company.
- AMTD Digital Inc. (NYSE:HKD) rose 28.4% to settle at $56.31 on continued post-IPO volatility.
- Greenbrook TMS Inc. (NASDAQ:GBNH) surged 24.6% to close at $2.38.
- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) rose 19.9% to settle at $1.69.
- Versus Systems Inc. (NASDAQ:VS) gained 19.6% to settle at $0.54 after the USPTO issued U.S. Patent No. 11,376,498 to the company to cover games and challenges that produce real world rewards inside of apps and streaming media.
- Evaxion Biotech A/S (NASDAQ:EVAX) gained 19.3% to close at $3.03. Oppenheimer recently assumed Evaxion Biotech with an Outperform rating and announced a price target of $16.
- Mustang Bio, Inc. (NASDAQ:MBIO) jumped 18.3% to close at $0.65.
- Covenant Logistics Group, Inc. (NASDAQ:CVLG) gained 18.1% to settle at $34.51 following better-than-expected Q2 results.
- Chimerix, Inc. (NASDAQ:CMRX) gained 17.7% to close at $2.40.
- Code Chain New Continent Limited (NASDAQ:CCNC) rose 17.7% to close at $0.3611 after dropping over 19% on Monday.
- Zenvia Inc. (NASDAQ:ZENV) surged 17.1% to settle at $2.46.
- ProKidney Corp. (NASDAQ:PROK) rose 16.1% to close at $11.25.
- Endo International plc (NASDAQ:ENDP) gained 16.1% to close at $0.5224.
- Vapotherm, Inc. (NASDAQ:VAPO) jumped 15.5% to settle at $2.38.
- Venus Concept Inc. (NASDAQ:VERO) rose 15.4% to close at $0.60.
- Talaris Therapeutics, Inc. (NASDAQ:TALS) gained 15.1% to settle at $4.51.
- Empire Petroleum Corporation (NYSE:EP) gained 14.7% to close at $10.39.
- Imperial Petroleum Inc. (NASDAQ:IMPP) rose 14.6% to settle at $0.49.
- Redbox Entertainment Inc. (NASDAQ:RDBX) rose 14.1% to settle at $6.33.
- Calix Inc (NYSE:CALX) shares gained 13.7% to close at $50.38 after the company announced upbeat Q2 results and issued strong Q3 sales forecast.
- Bluejay Diagnostics, Inc. (NASDAQ:BJDX) rose 13.3% to settle at $1.41. Bluejay Diagnostics posted a Q2 loss of $0.10 per share.
- Encore Wire Corporation (NASDAQ:WIRE) shares jumped 10.5% to close at $122.50 after the company reported Q2 results.
- Shell Midstream Partners, L.P. (NYSE:SHLX) gained 10.3% to close at $16.05 after the company, and Shell USA, announced the two have reached a definitive merger agreement.
- Virax Biolabs Group Limited (NASDAQ:VRAX) rose 9.8% to close at $18.44 after the company announced it has launched distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits in response to the world's major Monkeypox outbreak.
- TrueBlue, Inc. (NYSE:TBI) gained 7.7% to close at $20.64 following upbeat Q2 earnings.
- GeoVax Labs, Inc. (NASDAQ:GOVX) gained 6.9% to close at $1.70. GeoVax Labs shares jumped 150% on Monday on news that WHO has declared Monkeypox a public health emergency over the weekend.
- Altisource Asset Management Corporation (NYSE:AAMC) rose 6.2% to close at $16.46. Altisource Asset Management recently announced it purchased 286,873 shares of its common stock from Putnam Focused Equity Fund at $10 per share.
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) rose 4.6% to settle at $1.15 after the company announced U.S. commercial launch of TheraClearX Acne Therapy System.
Losers
- Revelation Biosciences, Inc. (NASDAQ:REVB) shares dipped 51.4% to close at $0.4910 on Tuesday after the company reported pricing of $5 million public offering. Revelation Biosciences shares jumped 55% on Monday after the company announced the data from its Phase 1b CLEAR clinical study of REVTx-99b met the primary endpoint.
- Luokung Technology Corp. (NASDAQ:LKCO) fell 41.2% to close at $0.2350 after the company announced an $8 million registered direct offering priced at $0.30 per share.
- Exela Technologies, Inc. (NASDAQ:XELA) shares fell 36.4% to close at $1.85 amid effectiveness of a 1-for-20 reverse stock split of the company's common stock.
- Onion Global Limited (NYSE:OG) fell 32.1% to settle at $0.38 in sympathy with Walmart, which cut guidance amid inventory markdowns.
- Koss Corporation (NASDAQ:KOSS) fell 25.8% to close at $8.31. Koss shares jumped 45% on Monday following a Bloomberg Law report titled "Apple, Koss Reach Deal in AirPods Patent Case on Eve of Trial."
- Sundial Growers Inc. (NASDAQ:SNDL) fell 23.3% to close at $2.28 following effect of 1:10 reverse stock split.
- Trinseo PLC (NYSE:TSE) fell 22% to close at $33.52 after the company announced it will pause the sale process of its styrenics business.
- Cyteir Therapeutics, Inc. (NASDAQ:CYT) dropped 21.9% to settle at $2.71.
- Coinbase Global, Inc. (NASDAQ:COIN) fell 21.1% to close at $52.93.
- Vinco Ventures, Inc. (NASDAQ:BBIG) dipped 20.8% to close at $0.7920. Vinco Ventures postponed stockholder meeting from July 26, 2022 to August 23, 2022.
- Verb Technology Company, Inc. (NASDAQ:VERB) dropped 20.3% to close at $0.6699.
- JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 19% to close at $1.96.
- Dermata Therapeutics, Inc. (NASDAQ:DRMA) dropped 18.6% to close at $0.57.
- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) dropped 16% to settle at $8.82 after the company received a notice regarding the U.S. Patent Office Patent Trial and Appeal Board's decision to institute trial.
- BridgeBio Pharma, Inc. (NASDAQ:BBIO) fell 15.8% to settle at $9.29. BridgeBio Pharma announced interim results from PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia, the most common form of short-limbed dwarfism.
- The Aaron's Company, Inc. (NYSE:AAN) fell 15.3% to close at $13.13 after the company lowered its sales guidance for the full year.
- MINISO Group Holding Limited (NYSE:MNSO) fell 15% to close at $6.13. Blue Orca Capital issued a short report on MINISO Group.
- Jaguar Health, Inc. (NASDAQ:JAGX) fell 14.9% to close at $0.2850.
- Histogen Inc. (NASDAQ:HSTO) dipped 14.7% to settle at $2.67.
- Airspan Networks Holdings Inc. (NASDAQ:MIMO) fell 14.5% to close at $2.90.
- Missfresh Limited (NASDAQ:MF) dipped 14.5% to settle at $0.25.
- Zedge, Inc. (NYSE:ZDGE) fell 14.4% to close at $2.61.
- Nuvectis Pharma, Inc. (NASDAQ:NVCT) declined 14.3% to settle at $9.54.
- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) dipped 14.2% to close at $1.1150. Kaival Brands recently announced the launch of PMI's self-contained e-vapor product, VEEBA, in Canada.
- Shopify Inc. (NYSE:SHOP) dropped 14.1% to close at $31.55 after the company announced it will lay off 10% of its workforce.
- Borqs Technologies, Inc. (NASDAQ:BRQS) fell 13.7% to close at $1.20.
- NextPlay Technologies, Inc. (NASDAQ:NXTP) fell 13.6% to close at $0.2428.
- Party City Holdco Inc. (NYSE:PRTY) dipped 13.5% to settle at $1.09.
- SpringBig Holdings, Inc. (NASDAQ:SBIG) dropped 10.6% to close at $1.85.
- Rent-A-Center, Inc. (NASDAQ:RCII) fell 10.3% to close at $21.09.
- Cooper-Standard Holdings Inc. (NYSE:CPS) dropped 8.9% to close at $4.52.
- Walmart Inc. (NYSE:WMT) shares fell 7.6% to close at $121.98 after the company cut guidance for the second quarter and full fiscal year. Walmart said it revised its outlook as a result of pricing actions aimed to improve inventory levels at Walmart and Sam's Club in the U.S. and mix of sales.
